yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37119978-423905A4-130A-4979-9DD5-95408FB99D6B
Q37119978-423905A4-130A-4979-9DD5-95408FB99D6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37119978-423905A4-130A-4979-9DD5-95408FB99D6B
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.
P2860
Q37119978-423905A4-130A-4979-9DD5-95408FB99D6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37119978-423905A4-130A-4979-9DD5-95408FB99D6B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f4103bad0f2b2e1a7d5e542e449bcf6d860e2dd
P2860
Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial.